Novavax (NVAX) EBT Margin (2010 - 2026)
Novavax (NVAX) reported EBT Margin of -91.14% for Q2 2026, down 136.06 percentage points from 44.91% a year earlier and down 85.05 percentage points from the prior quarter.
Novavax (NVAX) EBT Margin (2010 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Novavax's EBT Margin came in at -59.28%, down 99.27 percentage points year-over-year; for FY2025, it came in at 39.36%, up 65.25 percentage points from FY2024.
- EBT Margin has a five-year change of +127.30 percentage points (FY2020 to FY2025).
- By year, EBT Margin came in at -25.89% in FY2024 (+29.31 pp), -55.20% in FY2023 (-22.22 pp), -32.98% in FY2022 (+116.59 pp) and -149.57% in FY2021 (-61.63 pp).
- Five-year quarterly EBT Margin spans a low of -373.39% in Q4 2021 and a high of 77.98% in Q1 2025.
- Year over year, EBT Margin gained in three of the last eight quarters, with an average year-over-year change of -15.89 percentage points.
- The high point for year-over-year EBT Margin in five years was Q4 2022 (a gain of 321.77 percentage points); the low point was Q1 2023 (a drop of 390.88 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at -6.10% (Q1 2026), 12.17% (Q4 2025) and -288.22% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | 34.46% |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | 0.13% |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | 27.75% |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | 30.74% |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | 26.27% |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | 45.21% |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | 36.90% |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | 20.41% |
| 10 | Novavax | 1.80 Bn | -1.06 Bn | 44.81 Mn | -43.42% |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -43.42% |
| Jun 30, 2026 | -91.14% |
| Mar 31, 2026 | -6.10% |
| Dec 31, 2025 | 12.17% |
| Sep 30, 2025 | -288.22% |
| Jun 30, 2025 | 44.91% |
| Mar 31, 2025 | 77.98% |
| Dec 31, 2024 | -83.32% |
| Sep 30, 2024 | -144.75% |
| Jun 30, 2024 | 39.61% |
| Mar 31, 2024 | -154.80% |
| Dec 31, 2023 | -60.65% |
| Sep 30, 2023 | -70.31% |
| Jun 30, 2023 | 13.63% |
| Mar 31, 2023 | -361.60% |
| Dec 31, 2022 | -51.63% |
| Sep 30, 2022 | -22.62% |
| Jun 30, 2022 | -273.80% |
| Mar 31, 2022 | 29.27% |
| Dec 31, 2021 | -373.39% |
Novavax EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=NVAX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "NVAX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=NVAX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();